Département de Pharmacologie, Université Victor Segalen Bordeaux 2, Bordeaux, France.
J Ethnopharmacol. 2011 Jan 27;133(2):931-3. doi: 10.1016/j.jep.2010.11.019. Epub 2010 Nov 19.
Hydro-alcoholic extracts of Centaurium erythraea Rafn (CE), Gentianaceae and Artemisia herba-alba Asso (AHA), Asteraceae, medicinal plants used in traditional treatment of diabetes in north-eastern Algeria, were tested in established type 2 diabetes induced with a standardized high fat diet (HFD) in mice.
After confirmation of diabetes (17th week), plant extracts were administered orally by gavage at a dose of 2 g/kg daily for 18 weeks to male C57BL/6J mice fed HFD. Animals were weighed, food intake and plasma glucose measured weekly, insulin and lipid profile at study end.
At 35 weeks, groups treated with AHA or CE vs. HFD control had a significant reduction in mean (±SD) fasting blood glucose concentrations (143.8±23.9 and 139.5±14.2 vs. 229.0±20.8 mg/dL, p<0.05, respectively), triglyceride (18.9±11.1 and 16.0±6.5 vs. 62.8±18.3 mg/dL, p<0.05), total cholesterol (1.2±0.1 and 1.2±0.3 vs. 1.8±1.1 g/L, p<0.05) and serum insulin concentrations (1.7±0.7 and 0.9±0.7 vs. 3.3±14.3 ng/mL, p<0.05). Plant extracts also markedly reduced insulin resistance as compared to HFD controls (AHA: 15.6±9.1, CE: 9.0±7.7 vs. HFD control 38.5±30.3, p<0.05). The plant extracts decreased calorie intake and had little effect on body weight or HDL-cholesterol.
AHA has already been shown to have a antihyperglycaemic and antihyperlipidemic effect but this is the first demonstration of an effect of AHA and CE on established HFD-induced diabetes.
在东北阿尔及利亚,传统上用于治疗糖尿病的 Centaurium erythraea Rafn(CE)和 Artemisia herba-alba Asso(AHA)(Gentianaceae 和 Asteraceae)的水醇提取物在建立的 2 型糖尿病模型中进行了测试,该模型是由标准化高脂肪饮食(HFD)诱导的。
在第 17 周确认糖尿病后,将植物提取物通过灌胃以 2 g/kg 的剂量每天给药 18 周,给予喂食 HFD 的雄性 C57BL/6J 小鼠。每周测量动物体重、食物摄入量和血浆葡萄糖,在研究结束时测量胰岛素和血脂谱。
在 35 周时,与 HFD 对照组相比,AHA 或 CE 治疗组的空腹血糖浓度(143.8±23.9 和 139.5±14.2 与 229.0±20.8 mg/dL,p<0.05)、甘油三酯(18.9±11.1 和 16.0±6.5 与 62.8±18.3 mg/dL,p<0.05)、总胆固醇(1.2±0.1 和 1.2±0.3 与 1.8±1.1 g/L,p<0.05)和血清胰岛素浓度(1.7±0.7 和 0.9±0.7 与 3.3±14.3 ng/mL,p<0.05)均显著降低。与 HFD 对照组相比,植物提取物还显著降低了胰岛素抵抗(AHA:15.6±9.1,CE:9.0±7.7 与 HFD 对照组 38.5±30.3,p<0.05)。植物提取物减少了热量摄入,对体重或高密度脂蛋白胆固醇几乎没有影响。
AHA 已被证明具有降血糖和降血脂作用,但这是首次证明 AHA 和 CE 对已建立的 HFD 诱导的糖尿病有作用。